logo
Children's Hospital LA halts use of Sarepta's gene therapy for all patients

Children's Hospital LA halts use of Sarepta's gene therapy for all patients

India Today6 days ago
Children's Hospital Los Angeles has paused the use of Sarepta Therapeutics' gene therapy Elevidys for all patients with muscular dystrophy, following recent US Food and Drug Administration (FDA) actions that raised safety concerns.In a statement Monday, Children's Hospital LA said the pause has been communicated to affected patient families while it awaits any further determination by the FDA. The hospital is amongst more than 70 nationwide authorised to administer Elevidys. Five other major children's hospitals asked to comment on whether they planned to continue use of the gene therapy did not immediately respond, Reuters reported.advertisementThe decision, effective July 18, comes after the FDA asked Sarepta last week to voluntarily halt shipments of the treatment. The request followed the death of a muscular dystrophy patient who received a different, experimental gene therapy. Sarepta has so far refused to comply, stating it will "continue making the treatment available to ambulatory patients."
Elevidys was granted full FDA approval last year for children with Duchenne Muscular Dystrophy who can still walk, and received conditional approval for non-ambulatory patients. However, Sarepta suspended use in non-ambulatory cases in June, after two teenagers died of liver failure following treatment.The FDA's recent request reignited scrutiny of the therapy's safety profile. Shares of Sarepta, down about 90% year-to-date, fell 5% on Monday to close at $13.32 on Nasdaq.- EndsWith inputs from Reuters
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US lawmakers press FDA to target knockoff weight-loss drugs
US lawmakers press FDA to target knockoff weight-loss drugs

Time of India

timean hour ago

  • Time of India

US lawmakers press FDA to target knockoff weight-loss drugs

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market-a problem that emerged over the last year. Explore courses from Top Institutes in Please select course: Select a Course Category Cybersecurity MCA Data Science Degree Leadership PGDM Public Policy Operations Management others Others Product Management healthcare Digital Marketing MBA Technology Project Management CXO Finance Artificial Intelligence Healthcare Data Analytics Management Design Thinking Data Science Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details "We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications," they wrote in a letter to FDA commissioner Marty Makary. "Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo The group-spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey-asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the "urgency" of the situation. Live Events A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a "complete and thorough" response to the issues raised in the lawmakers' letter. "Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously," the spokesperson said. "And we are deeply committed to strengthening the oversight of imported products at US ports of entry." In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalise on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage but are no longer permitted to do so after Novo Nordisk and Eli Lilly boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalisations potentially linked to the copycat drugs, but that adverse events are likely being underreported. "We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs," said a spokesperson for Hims & Hers Health, one of the telehealth firms that sells compounded GLP-1s. "We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first." Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments.

Popular ice cream brands recalled across US after labeling error
Popular ice cream brands recalled across US after labeling error

Time of India

time2 hours ago

  • Time of India

Popular ice cream brands recalled across US after labeling error

More than a dozen popular ice cream products are being recalled nationwide after a labeling error that could put people with milk allergies at risk, the Food and Drug Administration ( FDA ) says. Tropicale Foods , based in Ontario, California, announced the voluntary recall Friday(July 25) for select Helados Mexico and La Michoacana ice cream products. The issue is the labels list 'cream' as an ingredient, but not 'milk,' a major allergen under federal law. Explore courses from Top Institutes in Please select course: Select a Course Category Operations Management PGDM Technology Finance Healthcare MBA Digital Marketing Project Management Cybersecurity Data Analytics Leadership Artificial Intelligence Management MCA others Product Management Data Science Design Thinking CXO Others Data Science Degree Public Policy healthcare Skills you'll gain: Quality Management & Lean Six Sigma Analytical Tools Supply Chain Management & Strategies Service Operations Management Duration: 10 Months IIM Lucknow IIML Executive Programme in Strategic Operations Management & Supply Chain Analytics Starts on Jan 27, 2024 Get Details 'People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products,' the company said in a statement posted to the FDA's website. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo What's affected The recall covers several single-flavor bars, coconut, strawberry , bubble gum, cookies and cream, and mango, along with 6-pack, 12-pack, and 16-pack multipacks sold nationwide. The affected 'best by' dates range from May 2026 to July 2027. Live Events Milk is one of nine major allergens that must be clearly labeled under federal law. Undeclared allergens can trigger severe reactions, including anaphylaxis, which can be life-threatening. So far, one illness linked to the recalled products has been reported, according to the company. What you should do If you have any of the recalled products and are allergic or sensitive to milk, do not eat them, the FDA warns. Consumers should throw them away or return them to the store for a refund. For questions, contact Tropicale Foods at 909-563-3090, Monday through Friday, from 8 am to 5 pm PT.

Jordan, UAE airdrop 25 tons of aid to Gaza for first time in months
Jordan, UAE airdrop 25 tons of aid to Gaza for first time in months

Hindustan Times

time4 hours ago

  • Hindustan Times

Jordan, UAE airdrop 25 tons of aid to Gaza for first time in months

Amid Gaza's peaking hunger crisis, Jordan and the United Arab Emirates on Sunday airdropped 25 tons of aid into the Gaza Strip, marking the first aid marks the first airdrop in months. As per the Gaza Health Ministry, 127 people, including 85 children, have died due to malnutrition since the war began nearly two years(AP) A Jordan official said that the air drops were not a substitute for delivery by land, reported Reuters. Two Jordanian Air Force C-130 Planes and one Emirati Plane dropped a total of 25 tonnes of aid to Gaza, according to Jordanian official sources. This is done to reduce the hunger crisis in Gaza. Earlier on Sunday, the Israeli military announced that it will implement a daily 'tactical pause' in three areas of Gaza, including the Muwasi, Deir al-Balah, and Gaza City. This 'tactical pause' halts military operations from 10 am to 8 pm local time starting Sunday until further notice, according to an AP news agency report. Along with this, the Israeli military also said that it had begun dropping aid into Palestinian territory after allegations of using starvation as a weapon against civilians. As per the Gaza health ministry, 127 people, including 85 children, have died due to malnutrition since the war began nearly two years ago. More than 100 NGOs have warned this week of "mass starvation". Also read: Palestinians stare at 'die hungry or leave territory' as Gaza starvation peaks, Israel blames Hamas again Meanwhile, Israel has faced International criticism after the crisis intensified following a total blockade that was imposed by Israel in March. In late May, Israel began allowing a trickle of aid, but UN and other humanitarian agencies have accused Israel of imposing excessive restrictions with tight control on road access. Egypt aid trucks enter Gaza Aid trucks from Egypt also began entering Gaza from Egypt on Sunday after the 'tactical pause' announced by Israel, AFP reported. The Egyptian state-linked media also had confirmed earlier that the movement of convoys, along with sharing footage of trucks near the border area. However, trucks crossing the Rafah border cannot enter Gaza directly as the Palestinian side of the crossing was seized by the Israeli military last year and has been badly damaged. To enter Gaza, these trucks will have to drive to the nearby Kerem Shalom (Karam Abu Salem) crossing, which is controlled by Israel. (With inputs from agencies)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store